Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

NCT00316563 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Anorexia
Taste Disorders
Olfactory Disorders

Interventions

DRUG: Marinol (Dronabinol)
OTHER: Placebo

Sponsor

Alberta Health services

Collaborators

[object Object]